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Top research priorities for preterm birth:
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Abstract
Background: We report a process to identify and prioritise research questions in preterm birth that are most
important to people affected by preterm birth and healthcare practitioners in the United Kingdom and Republic of
Ireland.
Methods: Using consensus development methods established by the James Lind Alliance, unanswered research
questions were identified using an online survey, a paper survey distributed in NHS preterm birth clinics and neonatal
units, and through searching published systematic reviews and guidelines. Prioritisation of these questions was by
online voting, with paper copies at the same NHS clinics and units, followed by a decision-making workshop of people
affected by preterm birth and healthcare professionals.
Results: Overall 26 organisations participated. Three hundred and eighty six people responded to the survey, and 636
systematic reviews and 12 clinical guidelines were inspected for research recommendations. From this, a list of 122
uncertainties about the effects of treatment was collated: 70 from the survey, 28 from systematic reviews, and 24 from
guidelines. After removing 18 duplicates, the 104 remaining questions went to a public online vote on the top 10. Five
hundred and seven people voted; 231 (45%) people affected by preterm birth, 216 (43%) health professionals, and 55
(11%) affected by preterm birth who were also a health professional. Although the top priority was the same for all
types of voter, there was variation in how other questions were ranked.
Following review by the Steering Group, the top 30 questions were then taken to the prioritisation workshop. A list of
top 15 questions was agreed, but with some clear differences in priorities between people affected by preterm birth
and healthcare professionals.
Conclusions: These research questions prioritised by a partnership process between service users and healthcare
professionals should inform the decisions of those who plan to fund research. Priorities of people affected by preterm
birth were sometimes different from those of healthcare professionals, and future priority setting partnerships should
consider reporting these separately, as well as in total.
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Background
Preterm birth has major impacts on survival, quality of
life, psychosocial and emotional stress on the family, and
costs for health services [1]. Improving outcome for
these vulnerable babies and their families is a priority,
and prioritising research questions is advocated as a
pathway to achieve this [2, 3].
Traditionally the research agenda has been determined
primarily by researchers, either in academia or industry,
who have used processes for priority setting that lack
transparency [4, 5]. This has contributed to a mismatch
between the available research evidence and the research
preferences of patients and members of the public, and of
clinicians [6, 7]. Often, research does not address the
questions about treatments that are of greatest importance
to patients, their carers and practising clinicians [5, 8].
The James Lind Alliance has developed methods for
establishing priority setting partnerships between patient
organisations and clinician organisations, which then
identify and prioritise treatment uncertainties in order to
inform publicly funded research [9, 10]. These methods
have been used for a range of health conditions [11–17].
We report the outcomes of a process to identify and
prioritise research questions in preterm birth that are
most important to people affected by preterm birth and
healthcare practitioners in the United Kingdom and
Ireland using methods established by the James Lind Al-
liance [18]. This partnership differed from previous pri-
ority setting partnerships supported by the James Lind
Alliance in that pregnancy is not an illness or disease,
and that it involves at least two people (mother and
child); in addition preterm birth can have life-long con-
sequences for them, their families and for the health
services and society. Our aim was first to identify un-
answered questions about the prevention and treatment
of preterm birth from people affected by preterm birth,
clinicians and researchers. Then to prioritise those ques-
tions that people affected by preterm birth and clinicians
agree are the most important.
Methods
The Preterm Birth Priority Setting Partnership was con-
vened in November 2011, following an introductory
meeting in July 2011. The partnership followed the four
stages of the James Lind Alliance process (see Fig. 1) [9].
Initiation
Organisations whose areas of interest included preterm
birth were informed about the priority setting partnership
and invited to participate in, or contribute to, the intro-
ductory workshop. Those who then joined the partnership
are listed in Box 1. All participating organisations were
asked to complete a declaration of interests, including
disclosure of relationships with the pharmaceutical or
medical devices industry. Subsequently a Steering Group
was convened, with members of participating organisa-
tions who volunteered to take on this role. This group was
chaired by a representative from the James Lind Alliance
(SC).
At the introductory workshop it was clear that many
participants felt the scope of the partnership should be
wider than was initially envisaged. Additional topics pro-
posed for inclusion in the scope were uncertainties
about the causes of preterm birth, about the prognosis
following being born preterm, and about treatments long
before birth. As widening the scope too far would risk
leaving the prioritisation unachievable within a reason-
able time frame and the existing resources, the Steering
Group decided the scope would be restricted to uncer-
tainties about treatments, to interventions during preg-
nancy and around the time of birth or shortly afterwards
(taken up to the time of hospital discharge for the baby
after birth).
Consultation to gather research questions (treatment
uncertainties)
Research questions were gathered from people affected
by preterm birth, clinicians and researchers, using
methods developed by the James Lind Alliance [10].
First, a survey was distributed on-line, including through
partner organisations, to ask for suggestions about pre-
term birth experiences, services or treatments which
needed to be researched, and why the research would be
important (see Additional file 1 for paper version of this
survey). Respondents were asked to say if they were
people with personal or family experiences of preterm
birth, and/or if they were a health professional.
At an interim review of demographic data about home
ownership and ethnicity from this survey there was con-
cern that the respondents were not representative of the
population at risk of preterm birth. To try and access a
more high risk group, paper copies of the survey (see
Additional file 1) were distributed at high risk specialist
prematurity antenatal clinics at two tertiary level hospi-
tals (University College London Hospital and Queen’s
Medical Centre Nottingham), and to parents visiting
their babies in three level 3 neonatal intensive care units
(University College London Hospital and Chelsea and
Westminster Hospital, London; Liverpool Women’s
Hospital) between March and December 2012. The
survey closing date was extended to allow time to imple-
ment these changes. Respondents were invited to pro-
vide an email address to be notified about voting to
prioritise the questions.
In addition, research questions were identified from
systematic reviews of existing research and from national
UK clinical guidelines (see Additional file 2).
Oliver et al. BMC Pregnancy and Childbirth          (2019) 19:528 Page 2 of 10
Collation - checking and combining research questions
With support from an independent information special-
ist, submissions from the survey were formatted into re-
search questions, which were checked against existing
reviews and guidelines. Those already answered were re-
moved. The remaining research questions were screened
by the Steering Group, to remove those answered by a
subsequent randomised trial or for which a large rando-
mised trial was in progress, and those that were out of
scope or unclear, and to combine similar research
questions. This left the final long list of unanswered re-
search questions which was sorted into similar categor-
ies, ordered chronologically from before pregnancy to
hospital discharge following birth.
Prioritisation of the research questions
Prioritisation was by a two-stage process using a modi-
fied Delphi with individual voting, followed by a face-to-
face workshop using nominal group technique [10].
First, the long list of unanswered research questions was
Fig. 1 Flow chart of the JLA Preterm Birth Priority Setting Partnership
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made available online for public voting (from September
to December 2013), with paper copies distributed to the
same high risk antenatal clinics and neonatal units.
Respondents were asked to pick the 10 they considered
most important. Overall results and results by stake-
holder group (people affected by preterm birth, health
professional) were reviewed by the Steering Group to re-
move remaining repetition or overlap between questions.
The final shortlist of 30 unanswered research questions
to go forward to the prioritisation workshop was then
agreed.
The aims of the prioritisation workshop were to agree
a ranking for the short list, including the ‘top10’, and to
consider next steps to ensure that the priorities are
taken forward for research funding. Participants were in-
vited from across the partnership, and included repre-
sentatives from organisations representing both people
affected by preterm birth and clinicians, parents of ba-
bies born preterm, and adults who were born preterm.
Prior to the workshop, participants were sent the short-
list of unanswered research questions.
At the workshop (held in January 2014), after an intro-
ductory session participants were assigned to one of four
small groups, each with a facilitator, to discuss ranking
for each uncertainty. Groups were pre-specified in ad-
vance to include a mix of parents, people born preterm,
clinicians and other health professionals. The groups
were provided with a set of 30 large cards, each printed
with one shortlisted research question. On the reverse
were examples of wording from the original submissions,
and a breakdown of how people affected by preterm
birth and healthcare professionals had scored that ques-
tion in their voting. Following discussion, these cards
were placed in ranked order. Over the lunchtime break,
rankings from the four groups were aggregated into a
single ranking order. These aggregate rankings were pre-
sented at a plenary session, to demonstrate where there
was existing consensus between groups, and where there
were differences. Participants were then reconvened into
three small groups, again pre-planned so each had a new
mix of participants and retained a balance of back-
grounds, to discuss the aggregate ranking. Similar pro-
cesses were used as in the earlier small groups, with the
aim of agreeing the top ten research questions and rank-
ing all 30 questions. Aggregated ranking from the three
small groups was taken to a final plenary session, with
the 30 cards laid out on the floor in ranked order. Par-
ticipants then debated and agreed the final ranking.
Results
Forty two organisations were approached and invited to
participate in the priority setting partnership (see
Additional file 4); of these 25 accepted and joined the part-
nership (see Table 1). Ten organisations were represented
on the Steering Group; four representing those affected by
preterm birth, and six representing health professionals
(obstetricians and neonatologists). Some Steering Group
members were parents of infants born preterm, or had
themselves been born preterm. The group also included
four non-voting members: two researchers who co-
ordinated the prioritisation partnership, one a clinical aca-
demic with a background in obstetrics and the other with
expertise in public engagement in research; one charity rep-
resentative, and one PhD student.
When the online survey closed it had been accessed by
1076 people, and completed by 349; an additional 37
paper survey forms were completed and returned. Hence
a total of 386 people responded of whom 204 (53%) said
that they were affected by preterm birth, 107 (28%) that
they were health professionals, 43 (11%) that they were
both affected by preterm birth and a health care profes-
sional, and 32 (8%) did not answer this question
(Table 2). Of the 247 respondents affected by preterm
birth, most 186 (75%) reported they were parents of a
preterm baby, but some were grandparents and other
family members.
The 386 responses contained 593 potential research
questions. Submissions were formatted into research
questions, with similar submission combined into one
question (see Additional file 5), and screened to remove
those already answered, out of scope or unclear, (see
Additional file 6). Thirty eight submissions were re-
moved as being outside the scope of this process. After
merging similar questions and removing those that were
fully answered, 70 unanswered questions were left from
the survey.
The search of systematic reviews and clinical guide-
lines identified 540 potentially relevant questions. As
there was such a large number, the Steering Group
agreed a process to prioritise which would go forward to
the next stage. Each member was asked to select the 60
questions from systematic reviews they considered to be
most relevant and important. They then brought their
list of 60 to a face-to-face meeting at which questions
were only considered as potential priorities for the vot-
ing stage if they were supported by three or more mem-
bers. This resulted in 28 questions from systematic
reviews and 24 from clinical guidelines remaining in the
process. Overall there were then 122 questions; as 18 of
these overlapped with other questions, they were merged
to give a final ‘long list’ of 104 unanswered research
questions (see Additional file 3).
The 104 questions on the long list were sent for an
online public vote, with paper copies distributed to the
same high risk antenatal clinics and neonatal units.
Overall 507 people voted (448 online and 59 on paper);
231 (45%) said they had been affected by preterm birth,
216 (43%) that they were a health professional, and 55
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(11%) that they were affected by preterm birth and also
a health professional (Table 2). Type of respondent was
not known for 5 (1%) voters. Of the 271 who said they
were a health professional (including those who had
been affected by preterm birth themselves), 85 said they
were an obstetrician, 51 a nurse, 44 a neonatologist, 24 a
midwife, 4 a general practitioner, 32 were other health
professionals and 31 preferred not to say. Of those who
voted, 512 (87%) reported their ethnicity as white, and
ethnicity was not known for 8 (2%). Responses were re-
ceived from the four nations within the United King-
dom, and from the Republic of Ireland.
For public voting, the top priority (which treatments
(including diagnostic tests) are most effective to predict
or prevent preterm birth?) was the same for all three
types of respondent (Table 3), but there was consider-
able variation in how other questions were ranked. Sev-
eral questions were in the overall top 10 for only one
type of voter. Questions ranked 1–40 in the public vote
were reviewed by the Steering Group, taking into ac-
count the voting preferences of people affected by pre-
term birth and the overall balance of the topics. Four
questions were removed: one had already been an-
swered, one was being addressed by an ongoing trial,
Table 2 Characteristics of respondents to the survey gathering research questions, and to voting about priorities
Gathering research questions
n = 386
Voting about priorities
n = 507
Type of respondent
Affected by preterm birth 204 (53%) 231 (45%)
Healthcare professional 107 (28%) 216 (43%)
Affected by preterm birth + healthcare professional 43 (11%) 55 (11%)
Not known 32 (8%) 5 (1%)
Gendera
Female 163 (42%) 422 (83%)
Male 9 (2%) 76 (15%)
Not known 214 (55%) 9 (2%)
Ethnicitya
White 159 (41%) 436 (86%)
Asian 4 (1%) 32 (6%)
Black 9 (2%) 5 (1%)
Chinese – – 1 (< 1%)
Mixed – – 8 (2%)
Not known 214 (55%) 25 (5%)
Home ownera 113 (46%)
aFor people affected by preterm birth only, n = 247 gathering research questions
Table 1 Partner organisations
Organisations representing people affected by
preterm birth
Both service users’ and clinicians’
organisations
Clinicians’ organisations
• Action on Pre-eclampsia
• Bliss, the special care baby charitya
• Irish Premature Babiesa
• Multiple Births Foundation
• Cleft Lip and Palate Association
• Irish Neonatal Health Alliancea
• National Childbirth Trusta
• Tiny Lifea
• Children’s Trust
• Tommy’s
• Association of Paediatric Anaesthetists of Great
Britain and Ireland
• British Academy of Childhood Disabilitya
• British Association of Paediatric Surgeons
• British Association of Perinatal Medicine
• British Paediatric Pathology Group
• British Maternal and Fetal Medicine Societya
• Cochrane Neonatal Group
• Department of Neonatal Medicine, Imperial Collegea
• MCRN Neonatal Clinical Studies Advisory Groupa
• Neonatal Nurses Association
• Obstetric Anaesthetists Association
• Paediatric Intensive Care Society
• Royal College of Anaesthetists
• Royal College of Obstetrician and Gynaecologistsa
• UCL Institute of Women’s Healtha
a Organisations represented on the Steering Group
Oliver et al. BMC Pregnancy and Childbirth          (2019) 19:528 Page 5 of 10
and two were merged with another broader question (all
three being about infant feeding). A shortlist of the top
30 questions was then taken forward to the prioritisation
workshop (Table 4).
The workshop to prioritise these 30 questions was
attended by 34 participants; 13 parents or adults who had
been born preterm and 21 health professions (neonat-
ology, obstetrics, midwifery, speech therapy and psych-
ology). Several of the health professionals also had
personal experience of preterm birth. In addition, there
were four facilitators (two from the James Lind Alliance
and two non-voting members of the Steering Group), five
observers (one from the James Lind Alliance, one from a
research funding organisation in Canada, one from the In-
stitute of Education University of London, and two who
were non-voting members of the Steering Group).
During the prioritisation workshop, two questions were
merged as it was agreed they overlapped, and the wording
of a few others was modified for clarification. Following
the first round of small group discussion, there was
considerable variation in the top priorities between the
four groups. Following the second round of small group
discussion there was agreement about the top few prior-
ities. During the final plenary discussion about the aggre-
gated ranking there was consensus about the top seven
questions, less consensus about the next three, and dis-
agreement about those ranked as between 10 and 20. As it
was not possible to achieve consensus about the top 10
questions within the timeframe, a proposal to expand this
to a top 15 was agreed. Consensus about the top 15 was
then achieved (Table 4). This top 15 had some significant
differences to the ranking following public voting. The
most noticeable was two questions ranked 18 (How do
stress, trauma and physical workload contribute to the risk
of preterm birth, are there effective ways to reduce those
risks and does modifying those risks alter outcome?) and
26 (What treatments can predict reliably the likelihood of
subsequent infants being preterm?) at the workshop were
ranked 3 and 4 respectively in the overall public vote, and
2 and 3 by service users in the public vote (Table 3).
Table 3 For the public vote: top 10 research questions by type of voter (those in italics cells were in the top 10 for one type of
voter only)
Type of respondent for public vote
Service user Health professional Service user & health professional
1 Which treatments (including diagnostic tests)
are most effective to predict or prevent
preterm birth?
Which treatments (including diagnostic tests)
are most effective to predict or prevent
preterm birth?
Which treatments (including diagnostic tests)
are most effective to predict or prevent
preterm birth?
2 What treatments can predict reliably the
likelihood of subsequent infants being
preterm?
What is the optimum milk feeding regimen, for
preterm infants, including quantity and speed
of feeding and use of donor and formula milks?
What is the optimum milk feeding regimen,
for preterm infants, including quantity and
speed of feeding and use of donor and
formula milks?
3 How do stress, trauma and physical workload
contribute to the risk of preterm birth, are
there effective ways to reduce those risks and
does modifying those risks alter outcome?
Which treatments are most effective to prevent
necrotising enterocolitis in preterm infants?
How do stress, trauma and physical workload
contribute to the risk of preterm birth, are
there effective ways to reduce those risks and
does modifying those risks alter outcome?
4 What should be included in packages of care
to support parents and families / carers when
a premature baby is discharged from hospital?
Which treatments are most effective to prevent
pre-eclampsia (for example, progesterone, cal
cium, garlic etc)?a
What should be included in packages of care
to support parents and families / carers when
a premature baby is discharged from hospital?
5 What is the optimum milk feeding regimen,
for preterm infants, including quantity and
speed of feeding and use of donor and
formula milks?
Which treatments are effective in preventing
spontaneous preterm birth in women with twin
and triplet pregnancies, especially in those at
high risk of preterm birth?a
What type of support is most effective at
improving breastfeeding in NICU / SCBU /
feeding clinics?
6 Which treatments are most effective to
prevent pre-eclampsia (for example, progester
one, calcium, garlic etc)?
What methods are most effective to predict risk of
preterm birth in order to allocate service
provision?a
What treatments can predict reliably the
likelihood of subsequent infants being
preterm?b
7 How can infection in preterm infants be
better prevented?d
Is routine transvaginal scanning during pregnancy
to detect short cervical length, and treatment,
cost effective?a
Is screening in the first trimester effective to
help prevent preterm birth?b
8 Can screening of the placenta be effective to
detect placenta abnormalities associated with
preterm birth?d
Is screening in the first trimester effective to
help prevent preterm birth?c
Which treatments are most effective to
prevent pre-eclampsia (for example,
progesterone, calcium, garlic etc)?
9 What is the best way to judge whether a baby
is feeling pain (for example, by their face,
behaviours or brain activities)?
Does screening and treatment for Group B
Streptococcus help to prevent preterm birth
and neonatal morbidity and mortality?c
Do preterm babies have better outcomes if
their parents have roomed in?
10 Is screening in the first trimester effective to
help prevent preterm birth?
What is the best time to clamp the umbilical
cord for preterm babies?
How can infection in preterm infants
be better prevented?
a, b, c, d these questions had the same number of votes within this type of voter category
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Discussion
The unanswered research questions relevant to preterm
birth identified during this process were prioritised in
the United Kingdom and Republic of Ireland by people
affected by preterm birth (parents, grandparents, adults
who were born preterm, and others affected by preterm
birth), by a range of health professionals, and by people
who were both personally affected by preterm birth and
a health professional. To our knowledge this is the first
such process in preterm birth. People affected by pre-
term birth and health professionals had many shared
priorities, but our process demonstrates that on some
questions they have different perspectives. Priorities may
also change over time and in different settings, Hence,
although the top research priorities from this process
should be considered by those who plan and fund
Table 4 For the prioritisation workshop: final ranking for the 29 research questions (two questions were merged due to overlap)
and ranking overall ranking from the public vote
Ranking following the prioritisation workshop Ranking from public
vote
1 Which treatments (including diagnostic tests) are most effective to predict or prevent preterm birth? 1
2 How can infection in preterm infants be better prevented? 8
3 Which interventions are most effective to prevent necrotising enterocolitis in preterm infants? 9
4 What is the best treatment for life-threatening lung damage in preterm infants? 20
5 What should be included in packages of care to support parents and families / carers when a premature baby is
discharged from hospital?
6
6 What is the optimum milk feeding strategy and guidance (including quantity and speed of feeding and use of donor and
formula milk) for the best long-term outcomes of premature babies?
2
7 What is the best way to judge whether a baby is feeling pain (for example, by their face, behaviours or brain activities)? 14
8 Which treatments are most effective to prevent early onset pre-eclampsia? 5
9a What emotional and practical support improves attachment and bonding, and does the provision of such support
improve outcomes for premature babies and their families?
25 / 28a
10 Which treatments are most effective for premature rupture of membranes? 16
11 What is the best time to clamp the umbilical cord for preterm babies? 19
12 What type of support is most effective at improving breastfeeding in NICU/SCBU/feeding clinics? 12
13 Which treatments are most effective to treat necrotising entercolitis in preterm infants? 22
14 Does specialist antenatal care for women at risk of preterm birth improve outcomes for mother and baby? 11
15 What are the best ways to optimise the environment (such as light and noise) in order to improve outcomes for
premature babies?
26
16 Is screening in the first trimester effective to help prevent preterm birth? 7
17 Which treatments are effective in preventing spontaneous preterm birth in women with twin and triplet pregnancies,
especially in those at high risk of preterm birth?
10
18 How do stress, trauma and physical workload contribute to the risk of preterm birth, are there effective ways to reduce
those risks and does modifying those risks alter outcome?
3
19 Is routine transvaginal scanning during pregnancy to detect short cervical length, and treatment, cost effective? 18
20 What guidance and information is most useful for parents at risk of having preterm infants? 21
21 Does screening and treatment for Group B Streptococcus help to prevent preterm birth and neonatal morbidity and
mortality?
15
22 What is the impact of length of orogastric / nasogastric feeding and reflux on early feeding development in preterm
infants?
24
23 What methods are most effective to predict risk of preterm birth in order to allocate service provision? 17
24 Can screening of the placenta be effective to detect placenta abnormalities associated with preterm birth? 13
25 What is the best way to encourage Kangaroo Mother Care more by staff in NICU for parents? 23
26 What treatments can predict reliably the likelihood of subsequent infants being preterm? 4
27 Do parents of preterm infants benefit from an open approach to notes and ward rounds? 27
28 Do preterm babies have better outcomes if their parents have roomed in? 29
29 Which lifestyle changes including gym, bed rest, posture and sexual intercourse are effective to minimise the risk of
preterm birth?
30
atwo original questions merged
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research in this area, the full list of 104 unanswered
questions is also relevant to decision-making about re-
search funding. This is particularly true if we wish to
make research more relevant to those whose lives have
been affected by preterm birth, and the healthcare
workers who care for them.
While several of the top priorities for research are
broad topics already well recognised as important, such
as what is the optimum milk feeding regimen for
preterm infants and prevention of infection, others are
indicative of areas previously underrepresented in re-
search; for example packages of care to support families
after discharge, and what is the role of stress, trauma
and physical workload in the risk of preterm birth, and
are there effective ways to reduce this risk and does this
influence outcome. This is in keeping with findings
from previous James Lind Alliance partnerships, which
suggests and highlights the value of partnership and
shared decision making with an inclusive stakeholder
group with balanced representation of service users and
clinicians [7].
In line with the literature on consensus development
[19], the strengths of this Preterm Birth Priority Setting
Partnership include the large numbers of participants in
the process, the range of stakeholders involved, the for-
mality of the processes, the use of facilitators for face-to-
face debate to ensure that all options were discussed and
all participants had a chance to voice their views, provid-
ing feedback and repeating the judgment, and ensuring
that judgements were made confidentially. The first
three features applied to both the consultation and the
workshop; the last applied only to the consultation. The
change in priorities between the survey and the work-
shop deserves further investigation. Although the choice
of individuals within the professional groups represented
is unlikely to have made a difference to the priorities,
[20] difference in status across workshop participants
may have [19].
Preterm birth is associated with factors such as lower
socio-economic status, ethnicity (such as African origin),
and maternal age (being lower than 18 years or above 35
years) [21]. Despite implementing strategies to reach a
more representative population, our respondents
remained primarily white and with a relatively high pro-
portion of homeowners, hence not representative of the
population affected by preterm birth. This could limit gen-
eralisablity of these priorities to other populations. A wide
range of relevant health professionals participated in the
public voting, including neonatologists, obstetricians, neo-
natal nurses, midwives, speech and language therapists,
psychologists and general practitioners; strengthening
generalisablity.
Maintaining balanced representation between people
affected by preterm birth and the different groups of
health professionals for the final prioritisation workshop
was challenging. This may have had implications for the
final decisions, as happens in guideline development,
where consensus development research concludes that
differences in how groups are constituted (but not indi-
vidual members) leads to different decisions [22]. At our
workshop differences in priorities between the various
professional groups contributed to the difficulty in
achieving consensus for a top 10 list, and to the two ‘lost
priorities’ which although ranked in the top 5 at the
public vote were not included in the final top 15. The
difficulty in agreeing a top 10 underlines the complexity
of priority setting for research, particularly for topics
such as preterm birth, which involve mother and baby,
as well as their wider family. This complexity, and the
differing priorities of different stakeholders, make it im-
portant to publicise the top 30 list, and the full long list
of 104 questions, as well as the top 15 priorities [23].
Large changes in ranking following the public vote and
the final prioritisation appeared to be related to difficulty
in the perspective of people affected by preterm birth
being heard in the large group session, and an imbalance
between the different priorities of two key types of
health professional (neonatologists and obstetricians).
This was further complicated by fewer obstetricians than
expected attending the workshop, and by some of the
healthcare professionals also being researchers. Another
element of our work, reported in detail elsewhere, was a
nested observational study of how service users and
healthcare professionals interact when making collective
decisions about research priorities [24]. This suggested
that health care professionals and service users tended
to use different pathways for persuasion in a group dis-
cussion, and communication patterns depended on the
stage of group development. The Steering Group had
worked together for some time, and when new partici-
pants joined for the workshop communication patterns
returned to an earlier stage. This may have influenced
quality of the consensus.
Reporting of the process for prioritisation is therefore
important for transparency, and to identify ways to im-
prove it. Future prioritisation processes, particularly those
with a similar wide range of healthcare professionals,
should endeavour to anticipate potential different perspec-
tives and mitigate any imbalance where possible, and
should report voting separately by ‘service users’ and
healthcare professionals. Similarly, whilst it may be appro-
priate to include healthcare professionals who are also
researchers in prioritisation, this potential conflict of inter-
est should be declared and taken into account.
This priority setting was limited to the United King-
dom and Ireland, and is therefore most readily generalis-
able to settings with a similar population and health
system. Previous research prioritisation processes for
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preterm birth [3, 25] did not include people affected by
preterm birth and were for low and middle income set-
tings. The most recent neonatal prioritisation exercise in
the UK did not include people affected by preterm birth
and considered only medicines for neonates [26]. Al-
though unanswered research questions are universal,
prioritisation of these questions depends on the local
values, context and setting. Nevertheless, there are com-
mon priorities across these different settings and our
prioritisation process in the UK, such as prevention of
preterm birth, postnatal infection and lung damage.
Failure to take account of the views of users of re-
search (i.e. clinicians and the patients who look to them
for help) contributes to research waste [27]. James Lind
Alliance priority setting partnerships brings together
‘patients, carers and clinicians’ to identify unanswered
research questions and to agree a list of the top prior-
ities, (http://www.jla.nihr.ac.uk/about-the-james-lind-al-
liance/about-psps.htm) which can then shape the
health research agenda [12–14]. The aim is to ensure
that those who fund health research, and also those
who support and conduct research, are aware of what
really matters to both patients and clinicians. In our
priority setting partnership, people affected by preterm
birth and the different groups of health care profes-
sionals had different priorities. This underlines the im-
portance of this paper presenting the full list of 30
questions taken forward to the prioritisation workshop,
and the respective priorities of people affected by pre-
term birth and health professionals, as well as the long
list of 104 unanswered questions sent out for public
voting.
Conclusions
We present the top 30 unanswered research questions
identified and prioritised by the priority setting partner-
ship, along with the full list of 104 questions. These in-
clude treatment and prevention as well as how care
should be organised and staff training. They should be
publicised to the public, to research funders and com-
missioners, and to those who support and conduct
research.
People affected by preterm birth and health profes-
sionals sometimes had different priorities. Future pri-
ority setting partnerships should consider reporting
the priorities of service users and healthcare profes-
sionals separately, as well as in total. Those with a
wide range of healthcare professionals involved should
anticipate potential different perspectives and mitigate
any imbalance where possible. Healthcare profes-
sionals who are also researchers should declare this
potential conflict before participating in prioritisation,
so that it can be taken into account.
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